文献速递消化道肿瘤与早癌消化内镜

巨噬细胞抑制性细胞因子-1/生长分化因子-15作为结肠肿瘤预测指标

Macrophage inhibitory cytokine-1/growth differentiation factor-15 as a predictor of colonic neoplasia.
PubMed 文献 · Aliment Pharmacol Ther · 2017-06-01

研究前瞻性招募单中心患者,分为无息肉、增生性息肉、无蒂锯齿状腺瘤、腺瘤和结直肠癌五组,检测结肠镜前后血清MIC-1/GDF15水平。结果显示基线血清MIC-1/GDF15中位数从无息肉组609 pg/mL升至腺瘤组723 pg/mL和结直肠癌组1107 pg/mL(P<.001),息肉切除后腺瘤组从722 pg/mL降至685 pg/mL(P=.002),ROC曲线下面积为0.71。作者认为血清MIC-1/GDF15具有提高结肠肿瘤检出和改善筛查的诊断特性。

要点

  • 基线血清MIC-1/GDF15中位数从无息肉组609 pg/mL升至腺瘤组723 pg/mL和结直肠癌组1107 pg/mL(P<.001)。
  • 腺瘤患者息肉切除后血清MIC-1/GDF15中位数从722 pg/mL降至685 pg/mL(P=.002)。
  • 血清MIC-1/GDF15识别腺瘤性息肉的ROC曲线下面积为0.71。

核心结论

  • 作者认为血清MIC-1/GDF15具有提高结肠肿瘤检出和改善筛查的诊断特性。

研究设计与样本

  • 前瞻性单中心研究,招募患者并分为无息肉、增生性息肉、无蒂锯齿状腺瘤、腺瘤和结直肠癌五组。
  • 共301名参与者,排除病理无法诊断9例(3%)和符合排除标准20例(6%)后,剩余272名受试者(男149,女123)。
  • 在结肠镜检查前和检查后4周采集血样,使用ELISA定量血清MIC-1/GDF15水平。

主要发现

  • 年龄(P=.005)、结肠息肉病史(P=.003)和结肠息肉家族史(P=.002)与腺瘤的存在相关。
  • 基线血清MIC-1/GDF15中位数从无息肉组609(460-797)pg/mL、增生性息肉组582(466-852)pg/mL、无蒂锯齿状腺瘤组561(446-837)pg/mL升至腺瘤组723(602-1122)pg/mL和结直肠癌组1107(897-1107)pg/mL(P<.001)。
  • 在息肉切除前后的配对腺瘤样本中,血清MIC-1/GDF15中位数从722(603-1164)pg/mL显著降至685(561-944)pg/mL(P=.002)。
  • 血清MIC-1/GDF15识别腺瘤性息肉的ROC曲线下面积为0.71。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15) concentration has been associated with colonic adenomas and carcinoma. AIMS: To determine whether circulating MIC-1/GDF15 serum concentrations are higher in the presence of adenomas and whether the level decreases after excision. METHODS: Patients were recruited prospectively from a single centre and stratified into five groups: no polyps (NP); hyperplastic polyps (HP); sessile serrated ademona (SSA); adenomas (AP); and colorectal carcinoma (CRC). Blood samples were collected immediately before and 4 weeks after colonoscopy. MIC-1/GDF15 serum levels were quantified using ELISA. RESULTS: Participants (n=301) were stratified as: NP; n=116 (52%), HP; n=37 (12%), SSA; n=19 (7%), AP; n=68 (23%); and CRC; n=3 (1%). Patients were excluded from the study due to nondiagnostic pathology (n=9, 3%) and exclusion criteria (n=20, 6%). In the 272 remaining subjects (M=149; F=123), age (P=.005), history of colonic polyps (P=.003) and family history of colonic polyps (P=.002) were associated with presence of adenomas. Baseline median MIC-1/GDF15 serum levels increased significantly from NP 609 (460-797) pg/mL, HP 582 (466-852) pg/mL, SSA 561 (446-837) pg/mL to AP 723 (602-1122) pg/mL and CRC 1107 (897-1107) pg/mL; (P<.001). In the pre- and postpolypectomy paired adenoma samples median MIC-1/GDF15 reduced significantly from 722 (603-1164) pg/mL to 685 (561-944) pg/mL (P=.002). A ROC analysis for serum MIC-1/GDF15 to identify adenomatous polyps indicated an area under the curve of 0.71. CONCLUSIONS: Our data suggest that serum MIC-1/GDF15 has the diagnostic characteristics to increase the detection of colonic neoplasia and improve screening.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Danta M, Barber DA, Zhang HP, et al. Macrophage inhibitory cytokine-1/growth differentiation factor-15 as a predictor of colonic neoplasia. Aliment Pharmacol Ther. 2017. PMID: 28569401. doi:10.1111/apt.14156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。